VGI Health Technology (XNEC:VTL) Change In Receivables : A$0.00 Mil (TTM As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology Change In Receivables?

VGI Health Technology's change in receivables for the quarter that ended in . 20 was A$0.00 Mil. It means VGI Health Technology's Accounts Receivable stayed the same from . 20 to . 20 .

VGI Health Technology's change in receivables for the fiscal year that ended in . 20 was A$0.00 Mil. It means VGI Health Technology's Accounts Receivable stayed the same from . 20 to . 20 .

VGI Health Technology's Accounts Receivable for the quarter that ended in . 20 was A$0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. VGI Health Technology's liquidation value for the six months ended in . 20 was A$0.00 Mil.

VGI Health Technology Change In Receivables Historical Data

The historical data trend for VGI Health Technology's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology Change In Receivables Chart

VGI Health Technology Annual Data

Trend

Change In Receivables

VGI Health Technology Semi-Annual Data

Change In Receivables

VGI Health Technology Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

VGI Health Technology (XNEC:VTL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

VGI Health Technology's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=		/		*	91
=

2. In Ben Graham's calculation of liquidation value, VGI Health Technology's accounts receivable are only considered to be worth 75% of book value:

VGI Health Technology's liquidation value for the quarter that ended in . 20 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=		-		+	0.75 *	+	0.5 *
=	0.00

VGI Health Technology Change In Receivables Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

VGI Health Technology (XNEC:VTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003

Website

https://www.vgiht.com

VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines